Illness Perception and Clinical Treatment Experiences in Patients with M. Maroteaux-Lamy (Mucopolysaccharidosis Type VI) and a Turkish Migration Background in Germany-Reference-Cited by-同舟云学术

Illness Perception and Clinical Treatment Experiences in Patients with M. Maroteaux-Lamy (Mucopolysaccharidosis Type VI) and a Turkish Migration Background in Germany

Published:2013-06-24 Issue:6 Volume:8 Page:e66804
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dilger Hansjörg,Leissner Linn,Bosanska Lenka,Lampe Christina,Plöckinger Ursula

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Prevalence of lysosomal storage diseases in Portugal;R Pinto;European Journal of Human Genetics,2004

2. Prevalence of lysosomal storage disorders;PJ Meikle;JAMA,1999

3. The frequency of lysosomal storage diseases in The Netherlands;BJ Poorthuis;Human Genetics,1999

4. Incidence of the mucopolysaccharidoses in Northern Ireland;J Nelson;Human Genetics,1997

5. An update on the frequency of mucopolysaccharide syndromes in British Columbia;RB Lowry;Human Genetics,1990

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucopolysaccharidosis Type VI with Recurrent Chest Infection;Cureus;2023-02-20

2. Quality of life, illness perceptions, and parental lived experiences in TANGO2-related metabolic encephalopathy and arrhythmias;European Journal of Human Genetics;2022-06-13

3. Fetal therapies and trials for lysosomal storage diseases: a survey of attitudes of parents and patients;Orphanet Journal of Rare Diseases;2022-01-29

4. Experiences of patients with lysosomal storage disorders who are receiving enzyme-replacement therapy and the experiences of their family members;JBI Evidence Synthesis;2021-11-26

5. Difficulties Associated with Enzyme Replacement Therapy for Mucopolysaccharidoses;Turkish Archives of Pediatrics;2021-11-19